---
figid: PMC9549209__fnut-09-987103-g007
figtitle: Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease
  progression
organisms:
- Armoracia rusticana
- Solanum lycopersicum
- Candida dubliniensis
- PX clade
- Spinacia oleracea
- Daucus carota
- Prunus armeniaca
- Saccharomyces boulardii nom. inval.
- Mus musculus
- Rattus norvegicus
- Escherichia coli
- Escherichia coli SCD1
- Homo sapiens
- Danio rerio
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9549209
filename: fnut-09-987103-g007.jpg
figlink: /pmc/articles/PMC9549209/figure/F7/
number: F7
caption: Graphical representation of proposed pathway in which carotenoid-rich orange
  carrots alleviate NAFLD severity. Orange carrots rich in α-carotene and β-carotene
  combated the severity of hepatic steatosis brought on by a high-fat diet by partially
  inhibiting fatty acid synthesis and significantly enhancing β-oxidation proteins,
  due to promotion of master regulators of hepatic lipid metabolism (i.e., p-AMPK,
  PGC-1α, PPARα).
papertitle: Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease
  progression.
reftext: Emilio Balbuena, et al. Front Nutr. 2022;9:987103.
year: '2022'
doi: 10.3389/fnut.2022.987103
journal_title: Frontiers in Nutrition
journal_nlm_ta: Front Nutr
publisher_name: Frontiers Media S.A.
keywords: phytochemicals | nutrition | beta-oxidation | nuclear receptors | lipid
  metabolism
automl_pathway: 0.8699053
figid_alias: PMC9549209__F7
figtype: Figure
redirect_from: /figures/PMC9549209__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9549209__fnut-09-987103-g007.html
  '@type': Dataset
  description: Graphical representation of proposed pathway in which carotenoid-rich
    orange carrots alleviate NAFLD severity. Orange carrots rich in α-carotene and
    β-carotene combated the severity of hepatic steatosis brought on by a high-fat
    diet by partially inhibiting fatty acid synthesis and significantly enhancing
    β-oxidation proteins, due to promotion of master regulators of hepatic lipid metabolism
    (i.e., p-AMPK, PGC-1α, PPARα).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SREBF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SCD
  - PPARGC1A
  - PPARA
  - ACOX1
  - CPT2
  - CD36
  - TG
  - Srebf1
  - Prkaa2
  - Scd
  - Ppara
  - Acox1
  - Cpt2
  - Cd36
  - Tg
  - scd
  - ppargc1a
  - pparab
  - acox1
  - cpt2
  - cd36
  - tg
  - Scd1
  - Abcg1
  - Ppargc1a
  - Scarb1
  - Tsc2
  - SREBP
  - SNF4Agamma
  - AMPKalpha
  - .na.character
  - srl
  - pgc
  - crq
---
